Precision BioSciences
DTIL
DTIL
100 hedge funds and large institutions have $60M invested in Precision BioSciences in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 35 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 102 → 100 (-2)
13% less capital invested
Capital invested by funds: $68.6M → $60M (-$8.63M)
40% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 35
Holders
100
Holding in Top 10
1
Calls
$26K
Puts
$14K
Top Buyers
| 1 | +$1.3M | |
| 2 | +$569K | |
| 3 | +$470K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$355K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$294K |
Top Sellers
| 1 | -$1.62M | |
| 2 | -$1.01M | |
| 3 | -$789K | |
| 4 |
Renaissance Technologies
New York
|
-$704K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$640K |